Transperineal ultrasound guided I-125/Pd-103 brachytherapy for early stage prostate cancer: Update on clinical experience at seven years

被引：4
|
作者：
Grimm, PD
Blasko, J
Ragde, H
Sylvester, J
Cavanagh, W
机构：
[1] SWEDISH MED CTR,NW PROSTATE INST,SEATTLE,WA
[2] UNIV WASHINGTON,MED CTR,DEPT RADIAT ONCOL,SEATTLE,WA 98195
[3] NORTHWEST HOSP,SEATTLE,WA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1997年 / 39卷 / 02期
关键词：
D O I：
10.1016/S0360-3016(97)80726-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：219 / 219
页数：1
相关论文
共 50 条
  • [1] Allegheny General Hospital experience with LDR prostate brachytherapy comparing Pd-103 with I-125
    Hall, Michael William
    Horn, Jeffrey
    Fuhrer, Russell
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [2] There is a wide range of predictive dosimetric factors for I-125 and Pd-103 prostate brachytherapy
    Herstein, Andrew
    Wallner, Kent
    Merrick, Gregory
    Orio, Peter
    Thornton, Ken
    Butler, Wayne
    Sutlief, Steven
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (01): : 6 - 10
  • [3] The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma
    Blasko, JC
    Grimm, PD
    Sylsvester, JE
    Cavanagh, W
    RADIOTHERAPY AND ONCOLOGY, 2000, 57 (03) : 273 - 278
  • [4] Theoretical determination of activities and numbers of I-125 and Pd-103 sources in ultrasound guided prostate implants
    Zhang, H
    Menyhart, G
    Meigooni, A
    MEDICAL PHYSICS, 2002, 29 (06) : 1227 - 1227
  • [5] Novel Plaques for Iris Melanoma I-125 and Pd-103 Brachytherapy
    Thomson, R.
    Furutani, K.
    Rogers, D.
    MEDICAL PHYSICS, 2009, 36 (06)
  • [6] Absolute calorimetric calibration of I-125 and Pd-103 brachytherapy sources
    Stump, KE
    DeWerd, LA
    MEDICAL PHYSICS, 2005, 32 (06) : 2128 - 2128
  • [7] Pd-103 and I-125 dose comparison for delivered ocular brachytherapy plans
    Larocque, Matthew
    Weis, Ezekiel
    Menon, Geetha
    MEDICAL PHYSICS, 2017, 44 (08) : 4385 - 4386
  • [8] Dosimetric Study of Cs-131, I-125, and Pd-103 Seeds for Permanent Prostate Brachytherapy
    Yang, Ruijie
    Wang, Junjie
    Zhang, Hongzhi
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (06) : 701 - 705
  • [9] I-125 or Pd-103 for brachytherapy boost in men with high-risk prostate cancer: A comparison of survival and morbidity outcomes
    Stone, Nelson N.
    Skouteris, Vassilios M.
    Rosenstein, Barry S.
    Stock, Richard G.
    BRACHYTHERAPY, 2020, 19 (05) : 567 - 573
  • [10] DOSIMETRIC COMPARISON OF PERMANENT PROSTATE BRACHYTHERAPY PLANS USING CS-131, I-125 AND PD-103 SEEDS
    Yang, R.
    Wang, J.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S416 - S416
12345